I look at it long-term. I've figured that we'll eventually get to 30 million shares fully diluted, which would add another 8 million in dilution. At an average issuance price of $30, that would be $240 million with another $40 million plus in options that could be exercised and the pivotal trial reimbursement should bring in around $25 million. So that $300 million potentially raised over the next few years at the current cash burn would provide 6 years of capital.
I look at it long-term. I've figured that we'll eventually get...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.00 |
Change
-0.030(0.50%) |
Mkt cap ! $92.99M | |||
| Open | High | Low | Value | Volume |
| $6.01 | $6.03 | $5.84 | $85.53K | 14.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 333 | $6.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.25 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |